Taiwanese Journal of Obstetrics and Gynecology
Volume 47, Issue 3 , Pages 327-329 , September 2008

Atrial Fibrillation With Rapid Ventricular Response in Pregnancy

  • Chia-Hui Lin
    • ,
  • Chien-Nan Lee

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr Chien-Nan Lee, Department of Obstetrics and Gynecology, National Taiwan University Hospital, 7, Chung-Shan South Road, Taipei, Taiwan

,Accepted 19 July 2007.

References 

  1. Cox JL , Gardner MJ . Treatment of cardiac arrhythmias during pregnancy . Prog Cardiovasc Dis . 1993;36:137–178
  2. Rotmensch HH , Rotmensch S , Elkayam U . Management of cardiac arrhythmias during pregnancy: current concepts . Drugs . 1987;33:623–633
  3. Perloff JK . Epidemiology of heart disease and pregnancy . In:  Zipes D ,  Rowlands D editor. Progress in Cardiology . Philadelphia: Lea & Febiger; 1992;
  4. Szekely P , Snaith L . Atrial fibrillation and pregnancy . Br Med J . 1961;5237:1407–1410
  5. Mason BA , Ricci-Goodman J , Koos B . Adenosine in the treatment of maternal paroxysmal supraventricular tachycardia . Obstet Gynecol . 1992;80:478–480
  6. Harrison JK , Greenfield RA , Wharton JM . Acute termination of supraventricular tachycardia by adenosine during pregnancy . Am Heart J . 1992;123:1386–1388
  7. Page RL . Treatment of arrhythmias during pregnancy . Am Heart J . 1995;130:871–876
  8. Joglar JA , Page RL . Treatment of cardiac arrhythmias during pregnancy: safety considerations . Drug Saf . 1999;20:85–94
  9. Fuster V , Ryden LE , Cannom DS , et al.   ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) . J Am Coll Cardiol . 2006;48:e149–e246
  10. Klein V , Repke J . Supraventricular tachycardia in pregnancy: cardioversion with verapamil . Obstet Gynecol . 1984;63(3 Suppl):16S–18S
  11. Byerly W , Hartmann A , Foster D , Tannenbaum A . Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia . Ann Emerg Med . 1991;20:552–554
  12. Widerhorn J , Bhandari AK , Bughi S , Rahimtoola SH , Elkayam U . Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy . Am Heart J . 1991;122:1162–1166
  13. Magee LA , Downar E , Sermer M , Boulton BC , Allen LC , Koren G . Pregnancy outcome after gestational exposure to amiodarone in Canada . Am J Obstet Gynecol . 1995;172:1307–1311

PII: S1028-4559(08)60133-3

doi: 10.1016/S1028-4559(08)60133-3

Taiwanese Journal of Obstetrics and Gynecology
Volume 47, Issue 3 , Pages 327-329 , September 2008

Article Tools